Cargando…

Isolation and Characterization of scFv Antibody against Internal Ribosomal Entry Site of Enterovirus A71

Enterovirus A71 (EV-A71) is one of the causative agents of hand-foot-mouth disease, which can be associated with neurocomplications of the central nervous system. A limited understanding of the virus’s biology and pathogenesis has led to the unavailability of effective anti-viral treatments. The EV-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hlaing, Su Thandar, Srimanote, Potjanee, Tongtawe, Pongsri, Khantisitthiporn, Onruedee, Glab-ampai, Kittirat, Chulanetra, Monrat, Thanongsaksrikul, Jeeraphong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298210/ https://www.ncbi.nlm.nih.gov/pubmed/37373012 http://dx.doi.org/10.3390/ijms24129865

Ejemplares similares

Host neuronal PRSS3 interacts with enterovirus A71 3A protein and its role in viral replication
por: Rattanakomol, Patthaya, et al.
Publicado: (2022)

Transcriptome of human neuroblastoma SH-SY5Y cells in response to 2B protein of enterovirus-A71
por: Suanpan, Kittisak, et al.
Publicado: (2022)

Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus
por: Glab-ampai, Kittirat, et al.
Publicado: (2017)

Publisher Correction: Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus
por: Glab-ampai, Kittirat, et al.
Publicado: (2018)

Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication
por: Pissawong, Tippawan, et al.
Publicado: (2013)

Production and Immunological Characterization of scFv Specific to Epitope of Opisthorchis viverrini Rhophilin-Associated Tail Protein 1-like (OvROPN1L)
por: Geadkaew-Krenc, Amornrat, et al.
Publicado: (2023)

Antibacterial mechanism of rhodomyrtone involves the disruption of nucleoid segregation checkpoint in Streptococcus suis
por: Traithan, Apichaya, et al.
Publicado: (2020)

Mutations in Streptomycin Resistance Genes and Their Relationship to Streptomycin Resistance and Lineage of Mycobacterium tuberculosis Thai Isolates
por: Hlaing, Yin Moe, et al.
Publicado: (2017)

Cell Penetrable Human scFv Specific to Middle Domain of Matrix Protein-1 Protects Mice from Lethal Influenza
por: Dong-din-on, Fonthip, et al.
Publicado: (2015)

Ophiophagus hannah Venom: Proteome, Components Bound by Naja kaouthia Antivenin and Neutralization by N. kaouthia Neurotoxin-Specific Human ScFv
por: Danpaiboon, Witchuda, et al.
Publicado: (2014)

Humanized-V(H)H Transbodies that Inhibit HCV Protease and Replication
por: Jittavisutthikul, Surasak, et al.
Publicado: (2015)

Toxic Marine Puffer Fish in Thailand Seas and Tetrodotoxin They Contained
por: Chulanetra, Monrat, et al.
Publicado: (2011)

Engineered Fully Human Single-Chain Monoclonal Antibodies to PIM2 Kinase
por: Kaewchim, Kanasap, et al.
Publicado: (2021)

Rhodomyrtone Modulates Innate Immune Responses of THP-1 Monocytes to Assist in Clearing Methicillin-Resistant Staphylococcus aureus
por: Srisuwan, Sutthirat, et al.
Publicado: (2014)

Human Superantibodies to 3CL(pro) Inhibit Replication of SARS-CoV-2 across Variants
por: Glab-ampai, Kittirat, et al.
Publicado: (2022)

Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)

scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

Correction: Kaewchim et al. Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies. Viruses 2023, 15, 1252
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

Nonspecificity in a nonimmune human scFv repertoire
por: Kelly, Ryan L., et al.
Publicado: (2017)

“Stapling” scFv for multispecific biotherapeutics of superior properties
por: Boucher, Lauren E., et al.
Publicado: (2023)

Targeting Emerging RNA Viruses by Engineered Human Superantibody to Hepatitis C Virus RNA-Dependent RNA Polymerase
por: Glab-ampai, Kittirat, et al.
Publicado: (2022)

Isolation and characterization of human anti-CD20 single-chain variable fragment (scFv) from a Naive human scFv library
por: Shams, Nasir, et al.
Publicado: (2022)

Targeting scFv-Fc-scTRAIL fusion proteins to tumor cells
por: Hutt, Meike, et al.
Publicado: (2018)

Novel Neutralizing Epitope of PEDV S1 Protein Identified by IgM Monoclonal Antibody
por: Thavorasak, Techit, et al.
Publicado: (2022)

Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity
por: Jittavisutthikul, Surasak, et al.
Publicado: (2016)

The effects of N-terminal insertion into VSV-G of an scFv peptide
por: Dreja, Hanna, et al.
Publicado: (2006)

Empowering scFv with effector cell functions for improved anticancer therapeutics
por: Zhang, Hongtao
Publicado: (2013)

Integrating scFv into xMAP Assays for the Detection of Marine Toxins
por: Shriver-Lake, Lisa C., et al.
Publicado: (2016)

The Four-State Equilibrium Unfolding of a scFv Antibody Fragment
por: Pedroso, Idolka, et al.
Publicado: (2002)

Humanization and directed evolution of the selenium-containing scFv phage abzyme
por: Xu, Yan, et al.
Publicado: (2018)

Engineered Human Monoclonal scFv to Receptor Binding Domain of Ebolavirus
por: Densumite, Jaslan, et al.
Publicado: (2021)

Enhancing epitope of PEDV spike protein
por: Thavorasak, Techit, et al.
Publicado: (2022)

Cell Penetrable Humanized-VH/V(H)H That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV
por: Thueng-in, Kanyarat, et al.
Publicado: (2012)

Impact of antibody framework residue V(H)-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme
por: Krauss, J, et al.
Publicado: (2004)

Production and characterisation of a recombinant scFv reactive with human gastrointestinal carcinomas
por: Kim, D-J, et al.
Publicado: (2002)

Generation and Characterization of an scFv Directed against Site II of Rabies Glycoprotein
por: Aavula, Shukra M., et al.
Publicado: (2011)

Production of scFv-Conjugated Affinity Silk Powder by Transgenic Silkworm Technology
por: Sato, Mitsuru, et al.
Publicado: (2012)

Early Detection of NSCLC with scFv Selected against IgM Autoantibody
por: Pedchenko, Tetyana, et al.
Publicado: (2013)

Development and identification of fully human scFv-Fcs against Staphylococcus aureus
por: Nian, Siji, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pb0pm89hsilg7tk5pg9j6fophi